Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway-Reference-Cited by-同舟云学术

Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway

Published:2022-09-02 Issue:9 Volume:17 Page:1029-1045
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Panecka-Hofman Joanna¹^ORCID,Poehner Ina²^ORCID,Wade Rebecca C.³⁴⁵^ORCID

Affiliation:

1. Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Warsaw, Poland

2. School of Pharmacy, University of Eastern Finland, Kuopio, Finland

3. Center for Molecular Biology (ZMBH), Heidelberg University, Heidelberg, Germany

4. Molecular and Cellular Modeling group, Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany

5. DKFZ-ZMBH Alliance and Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany

Funder

European Union’s Seventh Framework Programme for research, technological development

Polish National Science Centre

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2113776

Reference124 articles.

1. WHO. WHO - Trypanosomiasis, human African (sleeping sickness) [Internet]. 2022 [cited 2022 Jan 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness)

2. WHO. WHO - Chagas disease (American trypanosomiasis) [Internet]. 2022 [cited 2022 Jan 24]. Available from: https://www.who.int/health-topics/chagas-disease

3. WHO. WHO - Leishmaniasis [Internet]. 2022 [cited 2022 Jan 24]. Available from: https://www.who.int/health-topics/leishmaniasis

4. Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the Congo

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of New Leishmanicidal Compounds via Bioconjugation of Antimicrobial Peptides and Antileishmanial Guanidines;ACS Omega;2023-09-06

2. Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design;European Biophysics Journal;2023-08-22

3. State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation;Research and Reports in Tropical Medicine;2023-06

4. Kaurane-Type Diterpenoids as Potential Inhibitors of Dihydrofolate Reductase-Thymidylate Synthase in New World Leishmania Species;Antibiotics;2023-03-28

5. Emerging compounds and therapeutic strategies to treat infections fromTrypanosoma brucei: an overhaul of the last 5-years patents;Expert Opinion on Therapeutic Patents;2023-03-04